Given the data autophagy may curb both IL-12p70 and IL-23 (via IL-1) production (54, 60), autophagy modulation rather than biological therapy could prove beneficial on many fronts of IBD treatment. This evidence concerns the gene IL1B and inflammatory bowel disease.